[1]
Bunger, D., Rajani, A., Patel, L. and Sharma, S. 2022. Real-world utilization and acceptance of biosimilar bevacizumab in metastatic colorectal cancer in India. International Journal of Basic & Clinical Pharmacology. 11, 6 (Oct. 2022), 564–567. DOI:https://doi.org/10.18203/2319-2003.ijbcp20222629.